PAA 2.50% 20.5¢ pharmaust limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1338

  1. 8,913 Posts.
    lightbulb Created with Sketch. 1726
    I believe my sentiment says hold so no plan to jump ship, but I am sure that some investors could easily find reasons to jump ship, not only what I posted above but also the fact that they reported 5 years ago that there was not adverse affects from taking mpl, the fact that not only has Roger used the canine deal ax a carrot but also human phrase 2, covid phrase 1 trials as carrots and now we have OHD techn and covid phrase 2 to add to those carrots.

    But while shareholders remain wearing their rose coloured glasses nothing going to change.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.